Forte Biosciences Inc (FBRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 40,035 | 42,044 | 45,665 | 50,795 | 54,762 |
| TOTAL | $40,411 | $42,520 | $46,556 | $51,881 | $55,872 |
| Non-Current Assets | |||||
| PPE Net | N/A | N/A | N/A | 70 | 83 |
| Other Non-Current Assets | 893 | 786 | 834 | 936 | 1,113 |
| TOTAL | $893 | $786 | $834 | $1,006 | $1,196 |
| Total Assets | $41,304 | $43,306 | $47,390 | $52,887 | $57,068 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 576 | 946 | 2,330 | 985 | 1,206 |
| Accrued Expenses | 680 | 812 | 1,410 | 1,993 | 1,164 |
| TOTAL | $1,256 | $1,758 | $3,740 | $2,978 | $2,370 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $1,256 | $1,758 | $3,740 | $2,978 | $2,370 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 590 | 590 | 590 | 563 | 540 |
| Common Shares | 15 | 15 | 15 | 14 | 13 |
| Retained earnings | -75,732 | -73,165 | -69,824 | -62,073 | -56,261 |
| TOTAL | $40,048 | $41,548 | $43,650 | $49,909 | $54,698 |
| Total Liabilities And Equity | $41,304 | $43,306 | $47,390 | $52,887 | $57,068 |